Muchtar, Eli http://orcid.org/0000-0003-2210-2174
Therneau, Terry M.
Larson, Dirk R.
Gertz, Morie A.
Lacy, Martha Q.
Buadi, Francis K.
Dingli, David
Hayman, Suzanne R.
Kapoor, Prashant
Gonsalves, Wilson
Kourelis, Taxiarchis V.
Warsame, Rahma
Fonder, Amie
Hobbs, Miriam
Hwa, Yi Lisa
Leung, Nelson http://orcid.org/0000-0002-5651-1411
Russell, Stephen
Lust, John A.
Lin, Yi
Go, Ronald S. http://orcid.org/0000-0002-8284-3495
Zeldenrust, Steven
Kyle, Robert A.
Rajkumar, S. Vincent
Kumar, Shaji K. http://orcid.org/0000-0001-5392-9284
Dispenzieri, Angela
Article History
Received: 8 September 2018
Revised: 19 October 2018
Accepted: 24 October 2018
First Online: 23 January 2019
Compliance with ethical standards
:
: MAG: Consultancy (Milleniu) and honoraria (Celgene, Millenium, Onyx, Novartis, Smith Kline, Prothena, Ionis); MQL: Research funding (Celgene); DD: Research funding (Karyopharm Therapeutics, Amgen, and Millenium Pharmaceuticals); PK: Research funding (Takeda, Celgene, and Amgen); SKK: Consultancy (Celgene, Millennium, Onyx, Janssen, and BMS) and research funding (Celgene, Millennium, Novartis, Onyx AbbVie, Janssen, and BMS); AD: Research funding (Celgene, Millennium, Pfizer, and Janssen), Travel grant (Pfizer). The remaining authors declare that they have no conflict of interest.